Immune Design Corp.
Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof

Abstract:

This patent application relates generally to the treatment of cancer, and more particularly to the use of a pseudotyped lentivirus expressing IL-12 for the treatment of cancer.